查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447016

到 2030 年止咳糖浆市场预测 - 按产品类型、年龄层、配销通路和地理位置进行的全球分析

Cough Syrup Market Forecasts to 2030 - Global Analysis By Product Type, Age Group, Distribution Channel and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球止咳糖浆市场规模为 631,209 万美元，预计到 2030 年将达到 876,400 万美元，预测期内复合CAGR为 4.8%。常用于治疗咳嗽症状的非处方药是止咳糖浆。止咳糖浆通常含有祛痰剂、止咳剂，偶尔还含有抗组织胺作为活性成分。其主要目标是缓解喉咙刺激，减少咳嗽的衝动，并促进黏液鬆弛。此外，有些製剂也可能含有退烧药或止痛药。止咳糖浆有液体和糖浆等多种剂型，使用简单。

根据美国肺臟协会的说法，适当的呼吸健康对于整体健康至关重要，定期运动有助于维持强大的肺功能。

市场动态：

司机：

呼吸系统疾病的发生频率

止咳糖浆的需求很大程度上是由感冒、流感和过敏等呼吸道疾病的持续流行所推动的。由于世界各地有许多人患有这些疾病，因此一直需要止咳产品。此外，止咳糖浆成为寻求快速有效缓解与呼吸道问题相关的烦躁症状的人的首选。

克制：

解决根本原因的能力有限

止咳糖浆主要治疗呼吸系统疾病的症状，而不是根本原因。儘管它们可以缓解咳嗽和相关不适，但可能无法治疗疾病的根本原因。此外，具有健康意识的消费者对提供全面答案的疗法的需求不断增长，这可能会限制止咳糖浆市场的扩张。

机会：

对儿童止咳糖浆的需求不断增长

由于人们对儿科健康意识的不断增强以及对儿童友善药物的需求不断增长，因此有机会专门生产儿科止咳糖浆。口味对孩子有吸引力、剂量准确的产品会在市场上流行。此外，透过满足儿科消费者的特殊需求和偏好，製造商可以从这个市场利基中获得可观的利润。

威胁：

价格侵蚀和仿製药竞争

止咳糖浆市场因仿製药竞争的可能性而受到严重挑战。当专利到期后仿製药进入市场时，止咳糖浆的价格可能会下降。此外，知名品牌的市场占有率和获利能力可能会受到非专利替代品竞争加剧的影响，企业需要製定策略规划以保持竞争优势。

Covid-19 影响：

止咳糖浆市场受到了 COVID-19 大流行的多种影响。儘管由于人们越来越关注呼吸系统健康，最初对止咳糖浆等咳嗽和感冒药物的需求激增，但由于供应链、製造和分销的中断，该行业面临困难。封锁、社会疏离政策和经济不确定性影响了消费者的购买模式，导致消费者转向必需品和网路零售商。此外，疫情提高了人们对预防保健和整体健康价值的认识，这可能会影响人们对止咳糖浆的感受和使用方式。

止咳药/镇咳药市场预计将在预测期内成为最大的市场

预计份额最大的部分是止咳药和镇咳药。减充血剂，如右美沙芬，可以减轻咳嗽的衝动，进而缓解干咳、无效咳嗽。这一品类吸引了广泛的消费者，因为它能有效减轻咳嗽症状而不使人昏昏欲睡。此外，镇咳药经常用于非处方止咳糖浆配方中，因为它们有针对性地治疗持续咳嗽，这推动了对它们的需求。

预计在线药房领域在预测期内的CAGR最高

市场CAGR最高的是在线药品领域，其中还包括止咳糖浆等非处方药。由于可近性、便利性和消费者对网上购物的偏好等因素，网路药局变得越来越受欢迎。此外，客户可以使用线上平台，在家中舒适地存取多种选择、比较产品并进行购买。由于社交距离措施，COVID-19 大流行进一步加速了线上药局的采用。

占比最大的地区：

预计北美将控制止咳糖浆市场的最大份额。该地区的特点是庞大的消费群、完善的医疗基础设施和高度的医疗保健意识。由于呼吸道疾病较为常见，尤其是在冬季，因此对止咳糖浆有需求。此外，大型製药公司的存在和消费者对非处方药的偏好进一步支撑了北美市场。

复合CAGR最高的地区：

止咳糖浆市场预计将以欧洲地区最高的CAGR成长。该地区受益于更容易患呼吸系统疾病的老龄化人口、完善的医疗保健系统和较高的健康意识。此外，冬季感冒和流感季节的传播倾向增加了对止咳糖浆的稳定需求。由于欧洲倾向于自我药疗和非处方药，以及药物研究的进步，因此止咳糖浆市场有望持续成长。

主要进展：

2024年1月，领先的科技公司默克公司宣布与美国公司Inspirna, Inc. 就肌酸转运通道SLC6A8的一流口服抑製剂欧培那利达成许可协议，后续将针对SLC6A8进行靶向治疗。- 化合物。 Ompenaclid 目前正在一项 II 期研究中进行评估，用于 RAS 突变的晚期或转移性结直肠癌 (mCRC) 的二线治疗。

2023 年 9 月，雅培签署了收购 Bigfoot Biomedical 的最终协议，该公司为糖尿病患者开发智慧胰岛素管理系统。自 2017 年以来，两家公司一直致力于互联糖尿病解决方案。Bigfoot Unity 由 Bigfoot Biomedical 开发，是一款智慧胰岛素管理系统。它具有连接的胰岛素笔盖，使用整合的连续血糖监测 (iCGM)资料和医疗保健提供者的说明。

2023年1月，武田与和记医疗（中国）及其子公司和记医疗签署独家许可协议，开发和销售后者的呋喹替尼。根据交易条款，该公司将获得呋喹替尼所有适应症以及中国大陆、澳门和香港以外地区的开发和商业化的全球独家许可。

我们的报告提供了什么：

  • 区域和国家层面的市场份额评估
  • 对新进入者的策略建议
  • 涵盖2021年、2022年、2023年、2026年及2030年的市场资料
  • 市场趋势（驱动因素、限制因素、机会、威胁、挑战、投资机会和建议）
  • 根据市场预测提出关键业务部门的策略建议
  • 竞争性景观美化绘製主要共同趋势
  • 公司概况，包括详细的策略、财务状况和最新发展
  • 反映最新技术进步的供应链趋势

免费客製化产品：

本报告的所有客户都将有权获得以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 个）
    • 关键参与者的 SWOT 分析（最多 3 个）
  • 区域细分
    • 根据客户的兴趣对任何主要国家的市场估计、预测和CAGR（註：取决于可行性检查）
  • 竞争基准化分析
    • 根据产品组合、地理分布和策略联盟对主要参与者基准化分析

目录

第 1 章：执行摘要

第 2 章：前言

  • 抽象的
  • 股东
  • 研究范围
  • 研究方法论
    • 资料探勘
    • 数据分析
    • 数据验证
    • 研究方法
  • 研究来源
    • 主要研究来源
    • 二手研究来源
    • 假设

第 3 章：市场趋势分析

  • 介绍
  • 司机
  • 限制
  • 机会
  • 威胁
  • 产品分析
  • 新兴市场
  • Covid-19 的影响

第 4 章：波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争竞争

第 5 章：全球止咳糖浆市场：依产品类型

  • 介绍
  • 祛痰药
  • 止咳药/镇咳药
  • 抗组织胺药
  • 联合用药
  • 其他产品类型

第 6 章：全球止咳糖浆市场：依年龄段

  • 介绍
  • 儿科
  • 成人
  • 青少年

第 7 章：全球止咳糖浆市场：按配销通路

  • 介绍
  • 零售药房
  • 医院药房
  • 网路药房

第 8 章：全球止咳糖浆市场：依地理位置

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太地区其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 卡达
    • 南非
    • 中东和非洲其他地区

第 9 章：主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 扩充
  • 其他关键策略

第 10 章：公司概况

  • Takeda Pharmaceutical Company Limited
  • Abbott Laboratories
  • Johnson and Johnson Services, Inc
  • Merck & Co., Inc.
  • Bayer AG
  • Teva Pharmaceuticals Industries Ltd
  • Acella Pharmaceuticals, LLC
  • Sun Pharmaceutical Industries Ltd.
  • Novartis International AG
  • Reckitt Benckiser Group Plc.
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • AstraZeneca PLC
  • Pfizer Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Cipla Ltd
Product Code: SMRC25277

According to Stratistics MRC, the Global Cough Syrup Market is accounted for $6312.09 million in 2023 and is expected to reach $8764.00 million by 2030 growing at a CAGR of 4.8% during the forecast period. An over-the-counter drug that is frequently used to treat cough symptoms is cough syrup. Cough syrup usually contains expectorants, cough suppressants, and occasionally antihistamines as active ingredients. Its main goals are to ease throat irritation, lessen the urge to cough, and encourage mucus loosening. Moreover, some formulations may also contain fever reducers or pain relievers. Cough syrup comes in a variety of forms, such as liquids and syrups, it is simple to use.

According to the American Lung Association, proper respiratory health is crucial for overall well-being, and regular exercise can contribute to maintaining strong lung function.

Market Dynamics:

Driver:

Frequency of respiratory conditions

Cough syrup demand is largely driven by the ongoing prevalence of respiratory conditions like colds, the flu, and allergies. Since many people throughout the world suffer from these illnesses, there is a constant need for cough relief products. Furthermore, cough syrup becomes the go-to option for people looking for quick and efficient relief from irritable symptoms related to respiratory problems.

Restraint:

Limited ability to address fundamental causes

Cough syrups mainly treat the symptoms of respiratory disorders rather than their underlying causes. Although they alleviate coughing and associated discomfort, they might not treat the underlying cause of the illness. Additionally, the need for therapies that provide comprehensive answers is growing among health-conscious consumers, which could limit the market for cough syrup expansion.

Opportunity:

Growing need for children's cough syrups

There's a chance to create pediatric cough syrups specifically because of the growing awareness of pediatric health and the growing need for kid-friendly medications. Products with flavors that appeal to kids and dosages that are accurate can become popular on the market. Moreover, by catering to the particular needs and preferences of pediatric consumers, manufacturers can make significant profits from this market niche.

Threat:

Price erosion and generic competition

The market for cough syrup is severely challenged by the possibility of generic competition. Cough syrups may see price erosion when generic versions hit the market after a patent expires. Additionally, the market share and profitability of well-known brands may be impacted by increased competition from generic alternatives, necessitating strategic planning on the part of businesses to maintain a competitive advantage.

Covid-19 Impact:

The market for cough syrup has seen a variety of effects from the COVID-19 pandemic. Although there was initially a spike in demand for cough and cold remedies, such as cough syrups, due to the increased focus on respiratory health, the industry faced difficulties due to disruptions in supply chains, manufacturing, and distribution. Lockdowns, social distancing policies, and economic uncertainty affected consumer buying patterns, causing a move toward necessities and internet retailers. Furthermore, the pandemic increased people's awareness of the value of preventive care and general health, which may have an effect on how people feel about and use cough syrups.

The Cough Suppressants/Antitussives segment is expected to be the largest during the forecast period

The segment with the largest share is predicted to be cough suppressants and antitussives. Decongestants, like dextromethorphan, act by lessening the urge to cough, which relieves dry, ineffective coughs. This category appeals to a wide range of consumers because it effectively reduces cough symptoms without making people drowsy. Moreover, antitussives are frequently used in over-the-counter cough syrup formulations due to their targeted approach to treating persistent coughing, which drives demand for them.

The Online Pharmacy segment is expected to have the highest CAGR during the forecast period

The market's highest CAGR has been seen in the online pharmacy sector, which also includes over-the-counter drugs like cough syrups. Online pharmacies are becoming more and more popular due to factors like accessibility, convenience, and consumer preference for online shopping. Additionally, customers can access a multitude of options, compare products, and make purchases from the comfort of their homes with the help of the online platform. Due to social distancing measures, the COVID-19 pandemic has expedited the adoption of online pharmacies even more.

Region with largest share:

It is projected that North America will control the largest share of the cough syrup market. The area is distinguished by a sizable consumer base, a well-established healthcare infrastructure, and high healthcare awareness. There is a demand for cough syrups because respiratory conditions are more common, especially in the winter months. Furthermore, the market in North America is further supported by the presence of large pharmaceutical companies and consumer preferences for over-the-counter medications.

Region with highest CAGR:

The cough syrup market is expected to grow at the highest CAGR in the European region. The area benefits from an aging population that is more susceptible to respiratory disorders, a well-established healthcare system, and high health awareness. Additionally, the wintertime cold and flu season's propensity to spread adds to the steady demand for cough syrups. Europe is positioned for continued growth in the cough syrup market due to its propensity for self-medication and over-the-counter remedies, as well as advances in pharmaceutical research.

Key players in the market

Some of the key players in Cough Syrup market include Takeda Pharmaceutical Company Limited, Abbott Laboratories, Johnson and Johnson Services, Inc, Merck & Co., Inc., Bayer AG, Teva Pharmaceuticals Industries Ltd, Acella Pharmaceuticals, LLC, Sun Pharmaceutical Industries Ltd., Novartis International AG, Reckitt Benckiser Group Plc., F. Hoffmann-La Roche Ltd, Sanofi, AstraZeneca PLC, Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline PLC and Cipla Ltd.

Key Developments:

In January 2024, Merck, a leading science and technology company, has announced a licensing agreement with US-based firm Inspirna, Inc. for ompenaclid, a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds. Ompenaclid is currently being evaluated in a Phase II study for the second-line treatment of RAS-mutated advanced or metastatic colorectal cancer (mCRC).

In September 2023, Abbott has entered a definitive agreement for the acquisition of Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes. Together, the companies have worked on connected diabetes solutions since 2017. Developed by Bigfoot Biomedical, Bigfoot Unity is a smart insulin management system. It features connected insulin pen caps that use integrated continuous glucose monitoring (iCGM) data and healthcare provider instructions.

In January 2023, Takeda has signed an exclusive licence agreement with HUTCHMED (China) and its subsidiary Hutchmed to develop and market the latter's fruquintinib. Under the deal terms, the company will have an exclusive global licence for the development and commercialisation of fruquintinib for all indications and territories outside of mainland China, Macau, and Hong Kong.

Product Types Covered:

  • Expectorants
  • Cough Suppressants/Antitussives
  • Antihistamines
  • Combination Medications
  • Other Product Types

Age Groups Covered:

  • Pediatric
  • Adult
  • Adolescents

Distribution Channels Covered:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cough Syrup Market, By Product Type

  • 5.1 Introduction
  • 5.2 Expectorants
  • 5.3 Cough Suppressants/Antitussives
  • 5.4 Antihistamines
  • 5.5 Combination Medications
  • 5.6 Other Product Types

6 Global Cough Syrup Market, By Age Group

  • 6.1 Introduction
  • 6.2 Pediatric
  • 6.3 Adult
  • 6.4 Adolescents

7 Global Cough Syrup Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail Pharmacy
  • 7.3 Hospital Pharmacy
  • 7.4 Online Pharmacy

8 Global Cough Syrup Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Takeda Pharmaceutical Company Limited
  • 10.2 Abbott Laboratories
  • 10.3 Johnson and Johnson Services, Inc
  • 10.4 Merck & Co., Inc.
  • 10.5 Bayer AG
  • 10.6 Teva Pharmaceuticals Industries Ltd
  • 10.7 Acella Pharmaceuticals, LLC
  • 10.8 Sun Pharmaceutical Industries Ltd.
  • 10.9 Novartis International AG
  • 10.10 Reckitt Benckiser Group Plc.
  • 10.11 F. Hoffmann-La Roche Ltd
  • 10.12 Sanofi
  • 10.13 AstraZeneca PLC
  • 10.14 Pfizer Inc.
  • 10.15 Eli Lilly and Company
  • 10.16 GlaxoSmithKline PLC
  • 10.17 Cipla Ltd

List of Tables

  • Table 1 Global Cough Syrup Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 4 Global Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 5 Global Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 6 Global Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 7 Global Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 8 Global Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 9 Global Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 10 Global Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 11 Global Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 12 Global Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 13 Global Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 14 Global Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 15 Global Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 16 North America Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
  • Table 17 North America Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 18 North America Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 19 North America Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 20 North America Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 21 North America Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 22 North America Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 23 North America Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 24 North America Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 25 North America Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 26 North America Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 27 North America Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 28 North America Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 29 North America Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 30 North America Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 31 Europe Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
  • Table 32 Europe Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 33 Europe Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 34 Europe Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 35 Europe Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 36 Europe Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 37 Europe Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 38 Europe Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 39 Europe Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 40 Europe Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 41 Europe Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 42 Europe Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 43 Europe Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 44 Europe Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 45 Europe Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 46 Asia Pacific Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
  • Table 47 Asia Pacific Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 48 Asia Pacific Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 49 Asia Pacific Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 50 Asia Pacific Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 51 Asia Pacific Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 52 Asia Pacific Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 53 Asia Pacific Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 54 Asia Pacific Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 55 Asia Pacific Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 56 Asia Pacific Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 57 Asia Pacific Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 58 Asia Pacific Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 59 Asia Pacific Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 60 Asia Pacific Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 61 South America Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 South America Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 63 South America Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 64 South America Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 65 South America Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 66 South America Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 67 South America Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 68 South America Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 69 South America Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 70 South America Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 71 South America Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 72 South America Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 73 South America Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 74 South America Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 75 South America Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 76 Middle East & Africa Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
  • Table 77 Middle East & Africa Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 78 Middle East & Africa Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 79 Middle East & Africa Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 80 Middle East & Africa Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 81 Middle East & Africa Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 82 Middle East & Africa Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 83 Middle East & Africa Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 84 Middle East & Africa Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 85 Middle East & Africa Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 86 Middle East & Africa Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 87 Middle East & Africa Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 88 Middle East & Africa Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 89 Middle East & Africa Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 90 Middle East & Africa Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)